Exploration of common genomic signatures of systemic juvenile idiopathic arthritis and Kawasaki disease. [PDF]
Zhong S, Li Y, Wu L, Di Y.
europepmc +1 more source
Emapalumab as a Life-Saving Therapy for Macrophage Activation Syndrome in Refractory Systemic Juvenile Idiopathic Arthritis with Trisomy 21. [PDF]
Akay N +5 more
europepmc +1 more source
Identification of core genes in systemic juvenile idiopathic arthritis based on 113 machine learning algorithms. [PDF]
Chen Q +9 more
europepmc +1 more source
Hypocomplementemia dynamics during tocilizumab therapy in systemic juvenile idiopathic arthritis: a retrospective longitudinal study. [PDF]
Ling J, Zhou Q, Xie F, Liu X.
europepmc +1 more source
Associations of Lymphocyte Subpopulations, Related Cytokines, Clinical Phenotypes, and Outcomes in Systemic Juvenile Idiopathic Arthritis. [PDF]
Lerkvaleekul B +5 more
europepmc +1 more source
Evaluation of the real-world safety of Canakinumab in the treatment of systemic juvenile idiopathic arthritis in children aged 0-16: a comprehensive analysis based on FAERS data. [PDF]
Xiao P +8 more
europepmc +1 more source
A case with systemic juvenile idiopathic arthritis treated with tofacitinib and rapamycin. [PDF]
Cam V, Sag E, Bilginer Y, Ozen S.
europepmc +1 more source
Innate Lymphoid Cell Phenotypic and Functional Alterations in Patients With Systemic Juvenile Idiopathic Arthritis. [PDF]
Quatrini L +19 more
europepmc +1 more source
UBE2D1 as a key biomarker in systemic juvenile idiopathic arthritis: a new perspective on diagnosis and disease activity assessment. [PDF]
Luo Q +12 more
europepmc +1 more source

